4 past transactions

Enable Medicine

Series A in 2022
Enable Medicine is a biotechnology company that accelerates insight discovery by generating, managing, and analyzing spatial biology data on the enable cloud platform. Run experiments, decrease costs, and accelerate time to insight. The Enable Cloud Platform provides a collaborative ecosystem and tools for generating, visualizing, and analyzing many biological image formats. Enable Medicine was established in 2019 by Aaron Mayer and Sunil Bodapati in Menlo Park, California.

Options MD

Pre Seed Round in 2021
Options MD is a telemedicine platform that provides personalized care for people suffering from severe and treatment-resistant mental illnesses.

Glyphic Biotechnologies

Seed Round in 2021
Glyphic Biotechnologies is a biotechnology company that develops a protein sequencing platform. While DNA can reveal biological insights, proteins provide the actual insights into the functions of our bodies. The company is in the process of developing a pioneering, next-generation protein sequencing platform that will empower researchers to acquire unprecedented insights into both biology and diseases.

Parallel Health

Seed Round in 2021
Powered by genomics, skin microbiome science, and machine learning, Parallel is an end-to-end next-generation skin health company providing derm telehealth, cutting-edge skin microbiome diagnostics, precision microbiome skincare, and personalized Rx
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.